共查询到20条相似文献,搜索用时 62 毫秒
1.
Thin filament proteins mutations associated with skeletal myopathies: Defective regulation of muscle contraction 总被引:1,自引:0,他引:1
Ochala J 《Journal of molecular medicine (Berlin, Germany)》2008,86(11):1197-1204
In humans, more than 140 different mutations within seven genes (ACTA1, TPM2, TPM3, TNNI2, TNNT1, TNNT3, and NEB) that encode
thin filament proteins (skeletal α-actin, β-tropomyosin, γ-tropomyosin, fast skeletal muscle troponin I, slow skeletal muscle
troponin T, fast skeletal muscle troponin T, and nebulin, respectively) have been identified. These mutations have been linked
to muscle weakness and various congenital skeletal myopathies including nemaline myopathy, distal arthrogryposis, cap disease,
actin myopathy, congenital fiber type disproportion, rod-core myopathy, intranuclear rod myopathy, and distal myopathy, with
a dramatic negative impact on the quality of life. In this review, we discuss studies that use various approaches such as
patient biopsy specimen samples, tissue culture systems or transgenic animal models, and that demonstrate how thin filament
proteins mutations alter muscle structure and contractile function. With an enhanced understanding of the cellular and molecular
mechanisms underlying muscle weakness in patients carrying such mutations, better therapy strategies can be developed to improve
the quality of life. 相似文献
2.
Zhao N Jiang M Han W Bian C Li X Huang F Kong Q Li J 《European journal of medical genetics》2011,54(3):351-353
Distal arthrogryposis (DA) is a group of rare, clinically and genetically heterogeneous disorders primarily characterized by congenital contractures of the limb joints. Recently, mutations in genes encoding the fast-twitch skeletal muscle contractile myofibers complex, including troponin I2 (TNNI2), troponin T3 (TNNT3), tropomyosine 2 (TPM2), and embryonic myosin heavy chain 3 (MYH3), and the slow-twitch skeletal muscle myosin binding protein C1 (MYBPC1) were confirmed to cause DA1, DA2A, and DA2B. DA2B, or Sheldon-Hall syndrome (SHS; MIM 601680), is intermediate to DA1 and DA2A, or Freeman-Sheldon syndrome (FSS; MIM193700), and shows prominent facial traits. This report describes a Chinese family with SHS over three generations in which all affected individuals showed vertical talus and one demonstrated preauricular tags on the face. Linkage analysis and PCR sequencing revealed a novel substitute mutation at a hot-spot site in TNNT3 (c.187C > T; p.R63C). This mutation was confirmed to cosegregate with the DA phenotype in affected individuals. SIFT and PolyPhen analyses suggest that the mutation is pathogenic. We report this mutation in TNNT3 and speculate that bilateral vertical talus, or severe clubfoot, might be a special characteristic for cases with the TNNT3 R63C mutation. 相似文献
3.
Cloning and characterization of a novel cardiac-specific kinase that interacts specifically with cardiac troponin I 总被引:5,自引:0,他引:5
Zhao Y Meng XM Wei YJ Zhao XW Liu DQ Cao HQ Liew CC Ding JF 《Journal of molecular medicine (Berlin, Germany)》2003,81(5):297-304
Cardiac-restricted genes play important roles in cardiovascular system. In an effort to identify such novel genes we identified a novel cardiac-specific kinase gene TNNI3K localized on 1p31.1 based on bioinformatics analyses. Sequence analysis suggested that TNNI3K is a distant family member of integrin-linked kinase. Northern blot and 76-tissue array analyses showed that TNNI3K is highly expressed in heart, but is undetectable in other tissues. Immunohistochemical analysis predominantly localized TNNI3K in the nucleus of cardiac myocytes. In vitro kinase assay showed that TNNI3K is a functional kinase. The yeast two-hybrid system showed that TNNI3K could directly interact with cardiac troponin I, results that were further confirmed by coimmunoprecipitation in vivo. Our data suggest that TNNI3K is a cardiac-specific kinase and play important roles in cardiac system. 相似文献
4.
An extended region of biallelic gene expression and rodent-human synteny downstream of the imprinted H19 gene on chromosome 11p15.5 总被引:1,自引:0,他引:1
There is increasing evidence for chromosomal domains containing multiple
imprinted genes and for domain-wide disruption of imprinting in certain
diseases. In a majority of Wilms' tumors (WTs) there is an abnormal
bipaternal pattern of expression at three imprinted loci, H19, IGF2 and
KIP2, clustered on chromosome 11p15.5. We previously described biallelic
expression of L23MRP, 40 kb downstream of H19. Here we map two additional
genes, the first encoding a ubiquitously expressed RNA, 2G7, and the second
encoding the fast isoform of skeletal muscle troponin-T (TNNT3), in the 55
kb of DNA downstream of L23MRP. 2G7 RNA is spliced and polyadenylated but
lacks long open reading frames. 2G7 and TNNT3 are biallelically expressed
in mid-fetal and adult human tissues and 2G7 shows persistent expression in
WTs. The rat homologue of L23MRP is highly conserved and lies within 85 kb
of H19 in a region of rat chromosome 1 which also contains IGF2 and TNNT3.
Parallel expression of H19 and TNNT3 in different adult skeletal muscle
types suggests that these genes may share an enhancer. These data outline
multiple contiguous loci downstream of H19 which escape functional
imprinting in humans. The rodent-human synteny of this region may
facilitate a search for an imprinting domain boundary.
相似文献
5.
The chromosomal location of the human fast skeletal muscle troponin C (TNNC2) gene was determined using somatic cell hybrids. PCR-based analysis of a 'monochromosomal' hybrid panel identified the presence of the TNNC2 gene on human chromosome 20 and subsequent analysis of the Genebridge4 radiation hybrid panel located the gene between D20S721 and GCT10F11 with a lod score of >3. 相似文献
6.
7.
Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy 总被引:2,自引:0,他引:2
Erdmann J Daehmlow S Wischke S Senyuva M Werner U Raible J Tanis N Dyachenko S Hummel M Hetzer R Regitz-Zagrosek V 《Clinical genetics》2003,64(4):339-349
Defects in nine sarcomeric protein genes are known to cause hypertrophic cardiomyopathy (HCM). Mutation types and frequencies in large cohorts of consecutive and unrelated patients have not yet been determined. We, therefore, screened HCM patients for mutations in six sarcomeric genes: myosin-binding protein C3 (MYBPC3), MYH7, cardiac troponin T (TNNT2), alpha-tropomyosin (TPM1), cardiac troponin I (TNNI3), and cardiac troponin C (TNNC1). HCM was diagnosed in 108 consecutive patients by echocardiography (septum >15 mm, septal/posterior wall >1.3 mm), angiography, or based on a state after myectomy. Single-strand conformation polymorphism analysis was used for mutation screening, followed by DNA-sequencing. A total of 34 different mutations were identified in 108 patients: 18 mutations in MYBPC3 in 20 patients [intervening sequence (intron) 7 + 1G > A and Q1233X were found twice], 13 missense mutations in MYH7 in 14 patients (R807H was found twice), and one amino acid change in TPM1, TNNT2, and TNNI3, respectively. No disease-causing mutation was found in TNNC1. Cosegregation with the HCM phenotype could be demonstrated for 13 mutations (eight mutations in MYBPC3 and five mutations in MYH7). Twenty-eight of the 37 mutation carriers (76%) reported a positive family history with at least one affected first-grade relative; only eight mutations occurred sporadically (22%). MYBPC3 was the gene that most frequently caused HCM in our population. Systematic mutation screening in large samples of HCM patients leads to a genetic diagnosis in about 30% of unrelated index patients and in about 57% of patients with a positive family history. 相似文献
8.
Brenda Gerull Karl-Josef Osterziel Christian Witt Rainer Dietz Ludwig Thierfelder 《Human mutation》1998,11(2):179-182
Mutations in the human cardiac troponin T gene (TNNT2) are associated with familial hypertrophic cardiomyopathy (FHC) linked to chromosome 1q3 (CMH2). Mutation analyses of TNNT2 have been restricted to RNA-based screening methods because only the TNNT2 cDNA sequence was known. We characterized the genomic structure of 15 TNNT2 exons spliced into the adult isoform. A protocol for rapid mutation detection based on direct sequencing of large PCR-amplified genomic DNA fragments revealed a known TNNT2 mutation (Phe110Ile) in one of 30 FHC probands. Three polymorphic short tandem repeat elements (D1S477, D1S2622, and D1S1723), useful for FHC pedigree analyses at CMH2, were shown to be physically tightly linked to TNNT2. Hum Mutat 11:179–182, 1998. © 1998 Wiley-Liss, Inc. 相似文献
9.
Nemaline myopathy and distal arthrogryposis associated with an autosomal recessive TNNT3 splice variant
下载免费PDF全文
![点击此处可从《Human mutation》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Sarah A. Sandaradura Amali Mallawaarachchi Beryl B. Cummings Leigh B. Waddell Kristi J. Jones Christopher Troedson Annapurna Sudarsanam Benjamin M. Nash Gregory B. Peters Elizabeth M. Algar Daniel G. MacArthur Kathryn N. North Susan Brammah Amanda Charlton Nigel G. Laing Meredith J. Wilson Mark R. Davis Sandra T. Cooper 《Human mutation》2018,39(3):383-388
A male neonate presented with severe weakness, hypotonia, contractures and congenital scoliosis. Skeletal muscle specimens showed marked atrophy and degeneration of fast fibers with striking nemaline rods and hypertrophy of slow fibers that were ultrastructurally normal. A neuromuscular gene panel identified a homozygous essential splice variant in TNNT3 (chr11:1956150G > A, NM_006757.3:c.681+1G > A). TNNT3 encodes skeletal troponin‐Tfast and is associated with autosomal dominant distal arthrogryposis. TNNT3 has not previously been associated with nemaline myopathy (NM), a rare congenital myopathy linked to defects in proteins associated with thin filament structure and regulation. cDNA studies confirmed pathogenic consequences of the splice variant, eliciting exon‐skipping and intron retention events leading to a frameshift. Western blot showed deficiency of troponin‐Tfast protein with secondary loss of troponin‐Ifast. We establish a homozygous splice variant in TNNT3 as the likely cause of severe congenital NM with distal arthrogryposis, characterized by specific involvement of Type‐2 fibers and deficiency of troponin‐Tfast. 相似文献
10.
Foster GE Nakano J Sheel AW Simpson JA Road JD Reid WD 《European journal of applied physiology》2012,112(10):3547-3558
The purpose of this study was to determine if serum levels of skeletal troponin I (sTnI, fast and slow isoforms) could provide a sensitive marker of respiratory muscle damage in healthy humans subjected to inspiratory loads. To accomplish this, we studied healthy, young (27?±?2?years, Mean?±?SEM, n?=?5) and middle-aged (55?±?5, n?=?5) men to (1) determine the magnitude, pattern, and time course of the presence of sTnI in the serum after a single 60?min bout of inspiratory threshold loading [ITL, ~70% of maximal inspiratory pressure (MIP)], (2) determine the distribution and magnitude of DOMS after loading, and (3) compare fast and slow sTnI levels, and their relationship to other markers/indices of muscle injury including delayed onset muscle soreness (DOMS), serum creatine kinase (CK) levels, and force generating capacity of the respiratory muscles [MIP and maximal expiratory pressure (MEP)]. There was a 24?±?4 and 27?±?3% increase in fast sTnI 1?hour (p?0.01) and 3?days (p?0.01) after ITL. Slow sTnI was elevated by 24?±?10% (p?0.05) 4?days postITL. Other indices of respiratory muscle injury such as CK, MIP and MEP did not show a difference in mean data following ITL; DOMS was slightly but significantly increased following ITL. Our results suggest that sTnI has superior sensitivity compared to other biomarkers/indices of skeletal muscle injury. Future studies examining the impact of respiratory muscle injury with ventilator weaning should consider using sTnI as a sensitive marker of skeletal muscle injury. 相似文献
11.
Gurtej K. Dhoot 《Journal of muscle research and cell motility》1988,9(5):446-455
Summary In the adult chicken, two groups of fast troponin T, the higher molecular weight (B1 and B2) present only in the pectoral muscle and the lower molecular weight (L1–L5) the only group present in the leg muscle, were identified by the immunoblotting procedure using monoclonal antibodies against fast skeletal troponin T. The presence of significant amounts of three major variants of leg muscle type troponin T (L3–L5), however, could also be detected in the adult chicken pectoral muscle. Although none of the antibodies cross-reacted with slow troponin T itself, the proportions of both leg and pectoral type troponin T variants belonging to the fast class varied in fast muscles that contained slow muscle fibres or fast muscles devoid of slow muscle cells.The troponin T present in the early embryonic skeletal muscles did not react with any of the antibodies raised against adult fast isoforms. The gradual expression of some of the adult isoforms of troponin T was detected at about day 13in ovo. However, the adult isoforms did not all appear simultaneously and their full complement was not achieved until after hatching. In addition to the increased number of bands in the leg type troponin T region, the presence of two other protein bands (neonatal forms) with slower electrophoretic mobility than the other fast isoforms of troponin T, was detected in post-hatch pectoral muscle tested at 1–12 weeks of age. These neonatal forms (N1 and N2) in the pectoral muscle were undetectable at eight months of age. The presence of breast type troponin T in the leg muscle was not detected with these antibodies at any stage of development. 相似文献
12.
Hypertrophic cardiomyopathy (HCM) is an autosomal dominant disease, which may afflict as many as 1 in 500 subjects (0.2%), being probably the most common hereditary cardiovascular disease and the most common cause of sudden cardiac death (SCD). Hypertrophic cardiomyopathy is characterized by the presence of unexplained left ventricular hypertrophy (in absence of hypertension, valvular disease, etc), which is usually asymmetric and involves the ventricular septum. Molecular genetic studies have identified eleven genes that code proteins of the sarcomere that are associated with the HCM; the beta-myosin heavy chain gene (MYH7), alpha-myosin heavy chain (MYH6), cardiac troponin T (TNNT2); cardiac troponin C (TNNC1), alpha-tropomyosin (TPM1), myosin binding protein-C (MYBPC3), cardiac troponin (TNNI3), essential and regulatory light chain genes (MYL3 and MYL2, respectively), cardiac alpha-actin gene (ACTC) and titin (TTN). The objective of this paper is the revision of the current state of the knowledge on (1) the organization and mutations of the HCM causing genes and their proteins and (2) the animal models developed for the study of the genes, mutations and proteins in the hypertrophic cardiomyopathy. 相似文献
13.
家族性肥厚型心肌病(FHCM)是一种常染色体显性遗传病, 由于编码心肌蛋白的基因突变引起,目前已识别出至少13个不同致病基因的200余种突变。目前,阐明FHCM的分子遗传学机制已经成为当前研究的热点之一。肌钙蛋白T通过与原肌宁蛋白结合,在将肌钙蛋白复合体锚钉到细肌丝上起重要作用。肌钙蛋白T基因突变是导致家族性肥厚型心肌病的主要原因,至今已经发现了大约30个突变,约占所有突变的15~20%。肌钙蛋白T基因突变所致FHCM有两个主要特征:(1)心肌肥厚程度较轻, 疾病外显率差别较大,(2)猝死率高。目前所发现的致FHCM突变,主要集中在肌钙蛋白T的T1和T2结构域。对肌钙蛋白T突变致FHCM分子机制的研究将有助于肥厚型心肌病的基因诊断和临床治疗。 相似文献
14.
Tissue expression of four troponin I genes and their molecular interactions with two troponin C isoforms in Caenorhabditis elegans 总被引:1,自引:0,他引:1
Ruksana R Kuroda K Terami H Bando T Kitaoka S Takaya T Sakube Y Kagawa H 《Genes to cells : devoted to molecular & cellular mechanisms》2005,10(3):261-276
Gene duplication is a major genetic event that can produce multiple protein isoforms. Comparative sequence and functional analysis of related gene products can provide insights into protein family evolution. To characterize the Caenorhabditis elegans troponin I family, we analyzed gene structures, tissue expression patterns and RNAi phenotypes of four troponin I isoforms. Tissue expression patterns were determined using lacZ/gfp/rfp reporter gene assays. The tni-1, tni-2/unc-27 and tni-3 genes, each encoding a troponin I isoform, are uniquely expressed in body wall, vulval and anal muscles but at different levels; tni-4 was expressed solely in the pharynx. Expressing tni-1 and -2 gene RNAi caused motility defects similar to unc-27 (e155) mutant, a tni-2 null allele. The tni-3 RNAi expression produced egg laying defects while the tni-4 RNAi caused arrest at gastrulation. Overlay analyses were used to assay interactions between the troponin I and two troponin C isoforms. The three body wall troponin I isoforms interacted with body wall and pharyngeal troponin C isoforms; TNI-4 interacted only with pharyngeal troponin C. Our results suggest the body wall genes have evolved following duplication of the pharynx gene and provide important data about gene duplication and functional differentiation of nematode troponin I isoforms. 相似文献
15.
Hui Wang Lin Wang Li Song Yan-Wan Zhang Jue Ye Rui-Xia Xu Na Shi Xian-Min Meng 《Brazilian journal of medical and biological research》2013,46(2):128-137
The phosphorylation of cardiac troponin I (cTnI) plays an important role in the
contractile dysfunction associated with heart failure. Human cardiac troponin
I-interacting kinase (TNNI3K) is a novel cardiac-specific functional kinase that
can bind to cTnI in a yeast two-hybrid screen. The purpose of this study was to
investigate whether TNNI3K can phosphorylate cTnI at specific sites and to
examine whether the phosphorylation of cTnI caused by TNNI3K can regulate
cardiac myofilament contractile function. Co-immunoprecipitation was performed
to confirm that TNNI3K could interact with cTnI. Kinase assays further indicated
that TNNI3K did not phosphorylate cTnI at Ser23/24 and Ser44, but directly
phosphorylated Ser43 and Thr143 in vitro. The results obtained
for adult rat cardiomyocytes also indicated that enhanced phosphorylation of
cTnI at Ser43 and Thr143 correlated with rTNNI3K (rat TNNI3K) overexpression,
and phosphorylation was reduced when rTNNI3K was knocked down. To determine the
contractile function modulated by TNNI3K-mediated phosphorylation of cTnI,
cardiomyocyte contraction was studied in adult rat ventricular myocytes. The
contraction of cardiomyocytes increased with rTNNI3K overexpression and
decreased with rTNNI3K knockdown. We conclude that TNNI3K may be a novel
mediator of cTnI phosphorylation and contribute to the regulation of cardiac
myofilament contraction function. 相似文献
16.
Krishan K Morgan MJ Zhao W Dhoot GK 《Journal of muscle research and cell motility》2000,21(6):527-536
We have cloned cDNA sequences of both rat and mouse slow troponin T gene. These sequences share a high level of homology with each other and with the human slow troponin T gene although we were unable to detect an alternatively spliced exon present at 3 end of human slow troponin T cDNA in either mouse or rat cDNAs. Northern blot analysis detected a high level expression of slow troponin T in adult mouse Soleus with a lower level expression in mixed postnatal skeletal muscles. Unlike late fetal and postnatal skeletal muscles in which slow troponin T expression is restricted to slow muscle fibre rich regions only, in situ hybridisation analysis detected this isoform to be highly expressed in somitic myotome and all muscle masses at 10–14 days of gestation after which its expression was rapidly downregulated. The unexpected expression of slow troponin T mRNA in fetal heart was apparent by both northern blotting and in situ hybridisation analyses. Slow troponin T mRNA in fetal heart was first detected at 10 day in utero reaching maximum levels of expression at 12–15 days gestation. The slow troponin T in the heart was mainly expressed in the ventral ventricles until day 15 after which low level expression was also observed in both atria. Slow troponin T mRNA in both atrium and ventricle was mainly expressed in outer wall of the myocardium although it was also expressed in interventricular septum. This study therefore shows that in addition to being a cell type specific marker during later fetal and postnatal skeletal muscle development, slow troponin T represented one of the major developmental isoforms expressed in embryonic and fetal skeletal muscle as well as in the cardiac muscle. 相似文献
17.
In the present study, 10 zebrafish cDNA clones coding for muscle-specific proteins (MSPs) were characterized and most of them encode fast skeletal muscle isoforms. They are skeletal muscle alpha-actin (acta1), fast skeletal muscle a-tropomyosin (tpma), fast skeletal muscle troponin C (tnnc), fast skeletal muscle troponin T (tnnt), fast skeletal muscle myosin heavy chain (myhz1), fast skeletal muscle myosin light chain 2 (mylz2), fast skeletal muscle myosin light chain 3 (mylz3), muscle creatine kinase (ckm), parvalbumin (pvalb), and desmin (desm). Using these cDNA probes, their expression patterns in developing embryos and adults were compared by Northern blot hybridization and whole-mount in situ hybridization. All of the 10 genes are expressed in both embryos and adult fish, and the expression is highly abundant in skeletal muscle. Among them, acta1, tpma, tnnc, tnnt, myhz1, mylz2, mylz3 and pvalb, are expressed specifically in fast skeletal muscle while ckm and desm are expressed in both fast and slow skeletal muscles. In addition, tpma, ckm, and desm are also expressed in the heart. Ontogenetically, the onset of expression of these MSP genes in zebrafish skeletal muscle varies and the expression occurs rostral-caudally in developing somites. Shortly after the expression of myoD, desm is the first to be activated at approximately 9 hpf, followed by tpma (approximately 10 hpf), tnnc (approximately 12 hpf), acta1 (approximately 12 hpf), ckm (approximately 14 hpf), myhz1 (approximately 14 hpf), mylz2 (approximately 16 hpf), mylz3 (approximately 16.5 hpf), tnnt (approximately 16.5 hpf), and pvalb (approximately 16.5 hpf). At later stages (after 48 hpf), these MSP genes are also expressed in fin buds and head muscles including eye, jaw, and gill muscles. Thus, our experiment demonstrated the order of expression of the 10 MSP genes, which may reflect the sequence of muscle filament assembly. In spite of the asynchrony in activation of these MSP genes, the timing of expression for each individual MSP gene appears to be synchronous to somite development as each somite has an identical timetable to express the set of MSP genes. 相似文献
18.
Menon SC Michels VV Pellikka PA Ballew JD Karst ML Herron KJ Nelson SM Rodeheffer RJ Olson TM 《Clinical genetics》2008,74(5):445-454
We identified a unique family with autosomal dominant heart disease variably expressed as restrictive cardiomyopathy (RCM), hypertrophic cardiomyopathy (HCM), and dilated cardiomyopathy (DCM), and sought to identify the molecular defect that triggered divergent remodeling pathways. Polymorphic DNA markers for nine sarcomeric genes for DCM and/or HCM were tested for segregation with disease. Linkage to eight genes was excluded, but a cardiac troponin T (TNNT2) marker cosegregated with the disease phenotype. Sequencing of TNNT2 identified a heterozygous missense mutation resulting in an I79N substitution, inherited by all nine affected family members but by none of the six unaffected relatives. Mutation carriers were diagnosed with RCM (n = 2), non-obstructive HCM (n = 3), DCM (n = 2), mixed cardiomyopathy (n = 1), and mild concentric left ventricular hypertrophy (n = 1). Endomyocardial biopsy in the proband revealed non-specific fibrosis, myocyte hypertrophy, and no myofibrillar disarray. Restrictive Doppler filling patterns, atrial enlargement, and pulmonary hypertension were observed among family members regardless of cardiomyopathy subtype. Mutation of a sarcomeric protein gene can cause RCM, HCM, and DCM within the same family, underscoring the necessity of comprehensive morphological and physiological cardiac assessment in familial cardiomyopathy screening. 相似文献
19.
A comprehensive guide to genetic variants and post-translational modifications of cardiac troponin C
Reinoso Tyler R. Landim-Vieira Maicon Shi Yun Johnston Jamie R. Chase P. Bryant Parvatiyar Michelle S. Landstrom Andrew P. Pinto Jose R. Tadros Hanna J. 《Journal of muscle research and cell motility》2021,42(2):323-342
20.
Jennifer England Kar Lai Pang Matthew Parnall Maria Isabel Haig Siobhan Loughna 《Journal of anatomy》2016,229(3):436-449
The heart is the first functioning organ to develop during embryogenesis. The formation of the heart is a tightly regulated and complex process, and alterations to its development can result in congenital heart defects. Mutations in sarcomeric proteins, such as alpha myosin heavy chain and cardiac alpha actin, have now been associated with congenital heart defects in humans, often with atrial septal defects. However, cardiac troponin T (cTNT encoded by gene TNNT2) has not. Using gene‐specific antisense oligonucleotides, we have investigated the role of cTNT in chick cardiogenesis. TNNT2 is expressed throughout heart development and in the postnatal heart. TNNT2‐morpholino treatment resulted in abnormal atrial septal growth and a reduction in the number of trabeculae in the developing primitive ventricular chamber. External analysis revealed the development of diverticula from the ventricular myocardial wall which showed no evidence of fibrosis and still retained a myocardial phenotype. Sarcomeric assembly appeared normal in these treated hearts. In humans, congenital ventricular diverticulum is a rare condition, which has not yet been genetically associated. However, abnormal haemodynamics is known to cause structural defects in the heart. Further, structural defects, including atrial septal defects and congenital diverticula, have previously been associated with conduction anomalies. Therefore, to provide mechanistic insights into the effect that cTNT knockdown has on the developing heart, quantitative PCR was performed to determine the expression of the shear stress responsive gene NOS3 and the conduction gene TBX3. Both genes were differentially expressed compared to controls. Therefore, a reduction in cTNT in the developing heart results in abnormal atrial septal formation and aberrant ventricular morphogenesis. We hypothesize that alterations to the haemodynamics, indicated by differential NOS3 expression, causes these abnormalities in growth in cTNT knockdown hearts. In addition, the muscular diverticula reported here suggest a novel role for mutations of structural sarcomeric proteins in the pathogenesis of congenital cardiac diverticula. From these studies, we suggest TNNT2 is a gene worthy of screening for those with a congenital heart defect, particularly atrial septal defects and ventricular diverticula. 相似文献